Synthetic Biologics to Present at the 2014 BIO CEO & Investor Conference
ROCKVILLE, Md., Feb. 4, 2014 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious and other diseases, announced today that Jeffrey Riley, CEO, is scheduled to present at the BIO CEO & Investor Conference on Monday, February 10, 2014, at 10:00 a.m. […]
Synthetic Biologics to Present at the 2014 BIO CEO & Investor Conference Read More »